Formulary Committee members with a potential conflict of interest permission to participate in committee communications and discussions

Summary

The bill changes Minnesota law so that committee members who might have a conflict of interest can still participate in communications and discussions, but must recuse themselves from voting on those matters. It also requires the commissioner of Human Services to post any conflict disclosures online before meetings and to set up a public comment process for the committee’s recommendations. The changes affect the composition, operation, and transparency of the Formulary Committee that advises on drug coverage.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share